The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway

The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway

Due to the increasing incidence of malignant gliomas, particularly glioblastoma multiforme (GBM), a simple and reliable GBM diagnosis is needed to screen early the death-threaten patients. This study aimed to identify a protein that can be used to discriminate GBM from low-grade astrocytoma and eluc...

Full description

Bibliographic Details
Main Authors:	Chih-Wei Chen, Cheng-Han Yang, Yuan-Ho Lin, Ya-Chin Hou, Tain-Junn Cheng, Sheng-Tsung Chang, Yu-Hua Huang, Shang-Ting Chung, Chung-Ching Chio, Yan-Shen Shan, Hung-Chi Cheng, Wen-Tsan Chang
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	International Journal of Molecular Sciences
Subjects:	glioma glioblastoma multiforme (GBM) tumor recurrence tumor metastasis epithelial-mesenchymal transition (EMT) fibronectin (FN)
Online Access:	https://www.mdpi.com/1422-0067/22/7/3782

Similar Items

Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme
by: Mohammadreza Alizadeh, et al.
Published: (2023-09-01)

Metformin as Potential Therapy for High-Grade Glioma
by: Marek Mazurek, et al.
Published: (2020-01-01)

Leptomeningeal metastases in high-grade adult glioma: development, diagnosis, management and outcomes in a series of 34 patients.
by: Christopher eDardis, et al.
Published: (2014-11-01)

Current understanding of circulating tumor cells – potential value in malignancies of the central nervous system
by: Lukasz A. Adamczyk, et al.
Published: (2015-08-01)

Depleting RhoA/Stress Fiber-Organized Fibronectin Matrices on Tumor Cells Non-Autonomously Aggravates Fibroblast-Driven Tumor Cell Growth
by: Li-Tzu Huang, et al.
Published: (2020-11-01)

Role of extent of resection on the survival of glioblastoma multiforme
by: Dipak Chaulagain, et al.
Published: (2023-06-01)

Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration
by: Jiefei Xiao, et al.
Published: (2018-10-01)

Sprouty 1 is associated with stemness and cancer progression in glioblastoma
by: Seo-Young Park, et al.
Published: (2022-12-01)

Fibronectin glomerulopathy in a kidney allograft biopsy
by: Nathaniel Klair, et al.
Published: (2023-12-01)

FN1 mRNA expression of fibronectin 1 and distribution of fibronectin-associated leukocytes in humans with chronic diffuse liver diseases
by: H. V. Dolhikh, et al.
Published: (2020-05-01)

Three-Dimensional Tunable Fibronectin-Collagen Platforms for Control of Cell Adhesion and Matrix Deposition
by: Maryam Asadishekari, et al.
Published: (2022-02-01)

Characterizing Cell Stress and GRP78 in Glioma to Enhance Tumor Treatment
by: Kristie Liu, et al.
Published: (2020-12-01)

Protein phosphorylation: A potential target in glioma development
by: Yu Pi, et al.
Published: (2022-06-01)

Salvage Radiation Therapy for Patients With Relapsing Glioblastoma Multiforme and the Role of Slow Fractionation
by: I. Frank Ciernik, et al.
Published: (2020-12-01)

Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
by: Hayley Patricia Ellis, et al.
Published: (2014-03-01)

Photodynamic Therapy for the Treatment of Glioblastoma
by: Samuel W. Cramer, et al.
Published: (2020-01-01)

ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach
by: Iacopo Petrini, et al.
Published: (2022-05-01)

DeepAutoGlioma: a deep learning autoencoder-based multi-omics data integration and classification tools for glioma subtyping
by: Sana Munquad, et al.
Published: (2023-11-01)

Estradiol Induces Epithelial to Mesenchymal Transition of Human Glioblastoma Cells
by: Ana M. Hernández-Vega, et al.
Published: (2020-08-01)

Bioinformatic Analyses and Experimental Verification Reveal that High FSTL3 Expression Promotes EMT via Fibronectin-1/α5β1 Interaction in Colorectal Cancer
by: Yuanjie Liu, et al.
Published: (2021-11-01)

Clinical Application of Surface Plasmon Resonance-Based Biosensors for Fetal Fibronectin Detection
by: Chun Yu, et al.
Published: (2012-03-01)

Key Role of Staphylococcal Fibronectin-Binding Proteins During the Initial Stage of Staphylococcus aureus Keratitis in Humans
by: Corantin Maurin, et al.
Published: (2021-11-01)

Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas
by: Kanish Mirchia, et al.
Published: (2020-07-01)

Diffusion tensor imaging, intra-operative neurophysiological monitoring and small craniotomy: Results in a consecutive series of 103 gliomas
by: Giorgio Carrabba, et al.
Published: (2022-09-01)

Reciprocal Supportive Interplay between Glioblastoma and Tumor-Associated Macrophages
by: Wenchao Zhou, et al.
Published: (2014-03-01)

Safety of Inhomogeneous Dose Distribution IMRT for High-Grade Glioma Reirradiation: A Prospective Phase I/II Trial (GLIORAD TRIAL)
by: Patrizia Ciammella, et al.
Published: (2022-09-01)

Exploring the relationship between age and prognosis in glioma: rethinking current age stratification
by: Zetian Jia, et al.
Published: (2022-09-01)

Disulfiram in glioma: Literature review of drug repurposing
by: Shiyu Zhong, et al.
Published: (2022-08-01)

A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas
by: Janet Schloss, et al.
Published: (2021-05-01)

Pre-clinical models for evaluating glioma targeted immunotherapies
by: Stephen C. Frederico, et al.
Published: (2023-01-01)

An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential <em>GSK3β</em>/<em>β-Catenin</em>/<em>STAT3</em>/<em>CD44</em> Suppressor with Anti-Glioblastoma Properties
by: Ntlotlang Mokgautsi, et al.
Published: (2021-02-01)

Relaxed fibronectin: a potential novel target for imaging endometriotic lesions
by: Belinda Trachsel, et al.
Published: (2024-02-01)

Transcriptome analysis revealed CENPF associated with glioma prognosis
by: Moxuan Zhang, et al.
Published: (2021-04-01)

A child with genetic FN1 mutation in the absence of classic glomerulopathy with fibronectin deposits(GFND) findings on biopsy
by: Xiao-qing Yang, et al.
Published: (2022-07-01)

Editorial: Improving responses to immunotherapy in glioblastoma multiforme
by: Stephanie E. B. McArdle, et al.
Published: (2024-04-01)

PD-L1 Expression Correlated with p53 Expression in Pediatric Glioblastoma Multiforme
by: Jakub Litak, et al.
Published: (2021-02-01)

Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
by: Jang Hyun Park, et al.
Published: (2022-02-01)

Primary spinal glioblastoma multiforme. Single center experience and literature review
by: Milos Jokovic, et al.
Published: (2021-06-01)

Changes of O<sup>6</sup>-Methylguanine DNA Methyltransferase (MGMT) Promoter Methylation in Glioblastoma Relapse—A Meta-Analysis Type Literature Review
by: Jonas Feldheim, et al.
Published: (2019-11-01)

Salvage fractionated Stereotactic Radiotherapy (fSRT) with or without chemotherapy and immunotherapy for recurrent Glioblastoma Multiforme: A single institution experience
by: Shaakir eHasan, et al.
Published: (2015-05-01)